NIH-funded research NIH-funded research

Understanding how brain cells interact with melanoma cancer cells

Official title: The interface of neurons and cancer

Funded at Univ of North Carolina Chapel Hill · NIH-11237287 · Data updated 2026-11-12

This study is looking at how a protein called TRIM9, which is found in both brain cells and melanoma (a type of skin cancer), affects how the cancer grows and spreads, with the hope of finding better treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startDecember 1, 2024
Project endAugust 31, 2026
Funding year2025
Award (this year)$3,000
NIH project number3F99CA294269-01S1
Project IDNIH-11237287 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with melanoma, particularly those with aggressive forms of the disease.

Less likely to help

Patients with non-melanoma skin cancers or those without any neurological involvement may not benefit from this research.

What this research studies

This research investigates the relationship between neurons and melanoma, a type of skin cancer. It focuses on a specific protein, TRIM9, which is found in both brain cells and melanoma cells, to understand how this interaction affects cancer progression. The study will explore how changes in the behavior of these cells can influence tumor growth and spread. By examining the cellular mechanisms involved, the research aims to uncover new insights into cancer biology that could lead to improved therapies.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating melanoma by targeting the interactions between cancer cells and neurons.

How similar studies have gone: While the specific approach of studying the neuron-cancer interface is relatively novel, there have been successful studies exploring the role of cellular interactions in cancer progression.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Lukasik, Kimberly — Univ of North Carolina Chapel Hill
  • Study coordinator: Lukasik, Kimberly

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.